- Home
- PED vs SNTI Comparison
PED vs SNTI Comparison
Compare PED & SNTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PED
- SNTI
- Stock Information
- Founded
- PED N/A
- SNTI 2016
- Country
- PED United States
- SNTI United States
- Employees
- PED N/A
- SNTI N/A
- Industry
- PED Oil & Gas Production
- SNTI Biotechnology: Pharmaceutical Preparations
- Sector
- PED Energy
- SNTI Health Care
- Exchange
- PED Nasdaq
- SNTI Nasdaq
- Market Cap
- PED 49.1M
- SNTI 53.6M
- IPO Year
- PED N/A
- SNTI N/A
- Fundamental
- Price
- PED $0.48
- SNTI $2.06
- Analyst Decision
- PED Strong Buy
- SNTI Strong Buy
- Analyst Count
- PED 1
- SNTI 4
- Target Price
- PED $1.50
- SNTI $8.75
- AVG Volume (30 Days)
- PED 164.5K
- SNTI 97.8K
- Earning Date
- PED 11-17-2025
- SNTI 11-13-2025
- Dividend Yield
- PED N/A
- SNTI N/A
- EPS Growth
- PED 156.43
- SNTI N/A
- EPS
- PED 0.11
- SNTI N/A
- Revenue
- PED $33,244,999.00
- SNTI N/A
- Revenue This Year
- PED N/A
- SNTI N/A
- Revenue Next Year
- PED $17.41
- SNTI $150.00
- P/E Ratio
- PED $4.40
- SNTI N/A
- Revenue Growth
- PED N/A
- SNTI N/A
- 52 Week Low
- PED $0.45
- SNTI $1.26
- 52 Week High
- PED $1.00
- SNTI $16.94
- Technical
- Relative Strength Index (RSI)
- PED 29.29
- SNTI 55.55
- Support Level
- PED $0.45
- SNTI $1.44
- Resistance Level
- PED $0.54
- SNTI $2.16
- Average True Range (ATR)
- PED 0.03
- SNTI 0.18
- MACD
- PED -0.01
- SNTI 0.02
- Stochastic Oscillator
- PED 12.21
- SNTI 80.56
About PED Pedevco Corp.
PEDEVCO Corp is an oil and gas company focused on oil and natural gas development, exploration, and production. The company focuses on legacy properties where there is a long production history, well-defined geology and existing infrastructure that can be leveraged when applying modern field management technologies. The current properties of the company are located in the San Andres formation of the Permian Basin, situated in West Texas and eastern New Mexico (the Permian Basin), and in the Denver-Julesberg Basin (D-J Basin) in Colorado and Wyoming.
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.